MedTrace Logo

Implementation of Bright Light Therapy ID

NCT06215235 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2025-09-25

No results posted yet for this study

Summary

Many adults with intellectual disabilities (ID) have depressive symptoms, which negatively impact their quality of life. A lot of of the non-medicinal forms of treatment are not or hardly suitable for people with ID. Bright light therapy (BLT) seems to be a good option. Earlier research has shown that BLT is applicable in this group and seems promising in terms of reducing depressive symptoms, without serious side effects.

In part 1 of this project we investigate the implementation of BLT at Amarant. We will take the lessons learned into part 2 of this project: the implementation of BLT at Abrona. We will evaluate this process and the outcomes.

Conditions

  • Depressive Symptoms

Interventions

OTHER

Bright light therapy

for 2 weeks the patient will take place for a 10.000lux lamp for 20-30 minutes.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-18
Primary Completion
2025-12-31
Completion
2026-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06215235 on ClinicalTrials.gov